Lu Li

Lu Li

Auto-generated profile, based on publicly available information

Lu Li

Department of Radiology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2024 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
XZXiuzhi Zhang
Xiuzhi Zhang
TLTianhao Liu
Tianhao Liu
CRChunxiao Ran
Chunxiao Ran
WWWeidan Wang
Weidan Wang
FPFengyuan Piao
Fengyuan Piao
DZDeWei Zhao
DeWei Zhao
Osteoarthritis (OA) is a degenerative joint disease caused by chronic inflammation that damages articular cartilage. At present, the treatment of OA includes drug therapy to relieve symptoms and joint replacement therapy for advanced OA. However, these palliatives cannot truly block the progression of the disease from the immunological pathogenesis of OA. In recent years, bone marrow mesenchymal stem cell (BMSC) transplantation has shown great potential in tissue engineering repair. In addition, many studies have shown that BMSC paracrine signals play an important role in the treatment of OA through immune regulation and suppressing inflammation. At present, the mechanism of inflammation-induced OA and the use of BMSC transplantation in joint repair have been reviewed, but the mechanism and significance of BMSC paracrine signals in the treatment of OA have not been fully reviewed. Therefore, this article focused on the latest research progress on the paracrine effects of BMSCs in the treatment of OA and the related mechanisms by which BMSCs secrete cytokines to inhibit the inflammatory response, regulate immune balance, and promote cell proliferation and differentiation. In addition, the application potential of BMSC-Exos as a new type of cell-free therapy for OA is described. This review aimed to provide systematic theoretical support for the clinical application of BMSC transplantation in the treatment of OA.

18 April 2024 in Chemical Engineering Journal
Verified
Journal Article
Closed access
YWYanming Wang
Yanming Wang
AWAilin Wang
Ailin Wang
SLShiwei Liu
Shiwei Liu
LLLu Li
Lu Li
YLYue Liu
Yue Liu
Haillong YuHaillong Yu
Haillong Yu

2 January 2024 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
DZDeWei Zhao
DeWei Zhao
Liang ChengLiang Cheng
Liang Cheng
FLFaqiang Lu
Faqiang Lu
XZXiuzhi Zhang
Xiuzhi Zhang
JYJiawei Ying
Jiawei Ying
JLJunlei Li
Junlei Li
The joint prosthesis plays a vital role in the outcome of total hip arthroplasty. The key factors that determine the performance of joint prostheses are the materials used and the structural design of the prosthesis. This study aimed to fabricate a porous tantalum (Ta) hip prosthesis using selective laser melting (SLM) technology. The feasibility of SLM Ta use in hip prosthesis was verified by studying its chemical composition, metallographic structure and mechanical properties. In vitro experiments proved that SLM Ta exhibited better biological activities in promoting osteogenesis and inhibiting inflammation than SLM Ti6Al4V. Then, the topological optimization design of the femoral stem of the SLM Ta hip prosthesis was carried out by finite element simulation, and the fatigue performance of the optimized prosthesis was tested to verify the biomechanical safety of the prosthesis. A porous Ta acetabulum cup was also designed and fabricated using SLM. Its mechanical properties were then studied. Finally, clinical trials were conducted to verify the clinical efficacy of the SLM Ta hip prosthesis. The porous structure could reduce the weight of the prosthesis and stress shielding and avoid bone resorption around the prosthesis. In addition, anti-infection drugs can also be loaded into the pores for infection treatment. The acetabular cup can be custom-designed based on the severity of bone loss on the acetabular side, and the integrated acetabular cup can repair the acetabular bone defect while achieving the function of the acetabular cup.

1 May 2025 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
ZSZhao Shi
Zhao Shi
BHBin Hu
Bin Hu
MLMengjie Lu
Mengjie Lu
MZManting Zhang
Manting Zhang
HYHaiting Yang
Haiting Yang
FGfor the China Aneurysm AI Project Group
for the China Aneurysm AI Project Group
Radiologists assisted by the proposed sham–artificial intelligence (AI) model, acting as a placebo control for a standard-AI model to mitigate biases in intracranial aneurysm diagnosis, had noninferior sensitivity and specificity compared with radiologists alone.

19 September 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
YZYan Zhuang
Yan Zhuang
CLChenyu Li
Chenyu Li
HJHua Jiang
Hua Jiang
LLLu Li
Lu Li
YZYuanteng Zhang
Yuanteng Zhang
WFWeijun Fu
Weijun Fu
Background: Despite significant therapeutic advances over the last decade, multiple myeloma remains an incurable disease. Pomalidomide is the third Immunomodulatory drug that is commonly used to treat patients with relapsed/refractory multiple myeloma. However, approximately half of the patients exhibit resistance to pomalidomide treatment. While previous studies have identified Cereblon as a primary target of Immunomodulatory drugs’ anti-myeloma activity, it is crucial to explore additional mechanisms that are currently less understood.Methods: To comprehensively investigate the mechanisms of drug resistance, we conducted integrated proteomic and metabonomic analyses of 12 plasma samples from multiple myeloma patients who had varying responses to pomalidomide. Differentially expressed proteins and metabolites were screened, and were further analyzed using pathway analysis and functional correlation analysis. Also, we estimated the cellular proportions based on ssGSEA algorithm. To investigate the potential role of glycine in modulating the response of MM cells to pomalidomide, cell viability and apoptosis were analyzed.Results: Our findings revealed a consistent decrease in the levels of complement components in the pomalidomide-resistant group. Additionally, there were significant differences in the proportion of T follicular helper cell and B cells in the resistant group. Furthermore, glycine levels were significantly decreased in pomalidomide-resistant patients, and exogenous glycine administration increased the sensitivity of MM cell lines to pomalidomide.Conclusion: These results demonstrate distinct molecular changes in the plasma of resistant patients that could be used as potential biomarkers for identifying resistance mechanisms for pomalidomide in multiple myeloma and developing immune-related therapeutic strategies.